Switzerland· 60466004
Xeplion 100 mg, Depot-Injektionssuspension in einer Fertigspritze
A paliperidone product containing paliperidonum, natrium, registered in Switzerland by Janssen-Cilag AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Paliperidone is registered in 17 of 19 countries.
Countries holding a registration under ATC N05AX13 (paliperidone), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 10 of them publish a price we can compare per daily dose
Paliperidone · ATC N05AX13
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of paliperidone costs, country by country.
Normalised to the WHO defined daily dose (6 mg), the median price runs from $2.75 in Italy to $11.20 in Switzerland — a ×4.1 gap.
- Switzerland: $11.20 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Paliperidone · price per daily dose (6 mg)
USD · FX 28 Sept 2026
- CH Switzerland$11.20
- IT Italy$2.75
The record
At a glance
Swissmedic (Switzerland)- Active substance
- paliperidonum, natrium
- Manufacturer
- Janssen-Cilag AG
- Country
- Switzerland (CH)
- ATC code
- N05AX13
- ATC class
- Paliperidone
- Defined daily dose
- 6 mg, O
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680604660041Fertigspr 1 mlCHF 386
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
346 interactions on record for paliperidone.
Graded by severity as the source publishes them — 45 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Paliperidone · interactions on record
346 records
- 45 severe
- 252 moderate
- 2 minor
- 14 info
Most severe, free to view
- MetoclopramideA03FA01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- PasireotideH01CB05severe
33 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N05AX13
Paliperidone, as other registers publish it.
- FinlandBYANNLIJanssen-Cilag International NV
- FinlandBYANNLIJanssen-Cilag International NV
- FinlandBYANNLIJanssen-Cilag International NV
- FinlandBYANNLIJanssen-Cilag International NV
- FinlandBYANNLIJanssen-Cilag International NV
- FinlandBYANNLIJanssen-Cilag International NV
- FinlandBYANNLIJanssen-Cilag International NV
- PolandBYANNLIJanssen-Cilag International N.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d597b347-50e9-43da-a6bd-c44eec2360ce GET /v1/drugs/d597b347-50e9-43da-a6bd-c44eec2360ce?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "paliperidonum 100 mg",
"valid_from": "2011-03-01",
"limitations": null,
"galenic_form": "Inj Susp 100 mg/ml",
"therapeutic_area": null,
"sl_inclusion_date": "2011-03-01",
"self_retention_pct": 10
}See everything about paliperidone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.